3.29

6.13% 0.19

After Hours: 3.28 -0.01 -0.30%

Sophia Genetics Sa (SOPH)

Overview News Price History Option Chain Discussions Forecast

Sophia Genetics Sa stock is traded at $3.29, with a volume of 60,667. It is up +6.13% in the last 24 hours and up +9.67% over the past month. Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Previous Close:

$3.10

Open:

$3.06

24h Volume:

60,667

Relative Volume:

1.47

Market Cap:

$200.46M

Revenue:

$64.49M

Net Income/Loss:

$-71.40M

P/E Ratio:

-3.0183

EPS:

-1.09

Net Cash Flow:

$-52.00M

1W Performance:

+4.44%

1M Performance:

+9.67%

6M Performance:

+7.17%

1Y Performance:

-29.09%

1-Day Range:

$3.01

$3.40

1-Week Range:

$2.99

$3.40

52-Week Range:

$2.58

$4.92

Sophia Genetics Sa Stock (SOPH) Company Profile

Name

Sophia Genetics Sa

Sector

Healthcare (1166)

Industry

Health Information Services (53)

Phone

Address

Employee

423

Twitter

Next Earnings Date

2025-03-04

Latest SEC Filings

SOPH's Discussions on Twitter

Compare SOPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SOPH Sophia Genetics Sa	3.29	200.46M	64.49M	-71.40M	-52.00M	-1.09
VEEV Veeva Systems Inc	282.90	46.43B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	59.45	12.01B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	58.38	10.79B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	102.89	9.27B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	39.41	7.03B	906.14M	-52.62M	89.62M	-0.3621

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-18-24	Initiated	Craig Hallum	Buy
Aug-07-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-27-24	Initiated	Guggenheim	Buy
Nov-29-23	Initiated	RBC Capital Mkts	Outperform
Jul-05-23	Resumed	JP Morgan	Overweight
Jan-03-23	Initiated	BTIG Research	Buy
Nov-23-22	Initiated	Credit Suisse	Neutral
Oct-15-21	Resumed	Cowen	Outperform
Aug-17-21	Initiated	Cowen	Outperform
Aug-17-21	Initiated	Credit Suisse	Outperform
Aug-17-21	Initiated	JP Morgan	Overweight
Aug-17-21	Initiated	Morgan Stanley	Overweight

View All

Sophia Genetics Sa Stock (SOPH) Latest News

Jun 18, 2025

SOPHiA GENETICS Announces Key Approvals at 2025 Annual General Meeting - TipRanks

Jun 18, 2025

Jun 17, 2025

Precision Medicine Software Market Future Trends and Scope - openPR.com

Jun 17, 2025

Jun 16, 2025

Radiomics Market Key Players AnalysisRadiomics.io - openPR.com

Jun 16, 2025

Jun 11, 2025

SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 11, 2025

Jun 09, 2025

Innovation Fuels Rally for Tempus AI: Should You Buy the Stock Today? - sharewise

Jun 09, 2025

Jun 02, 2025

Millennium Management LLC Increases Position in SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World

Jun 02, 2025

May 19, 2025

Dimensional Fund Advisors LP Has $68,000 Stock Holdings in SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World

May 19, 2025

May 15, 2025

Top Market Trend Impacting AI In Bioinformatics Development in the Coming Years: Bionl.AI Platform Revoluti... - WhaTech

May 15, 2025

After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? - Yahoo Finance

May 15, 2025

May 14, 2025

SOPHiA GENETICS SA (NASDAQ:SOPH) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025

May 13, 2025